Obesity leaves a lasting imprint on fat and immune cells in ways that might make weight regain harder to avoid ...
Weight loss drugs are more popular than ever, even in cycling, but do the health benefits some are seeing outweigh the risks ...
The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...
The FDA approves the Allurion balloon for weight loss, which is swallowed and doesn't require a procedure for removal. Doctors explain how it works.
A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.
Verywell Health on MSN
Some people lost too much weight with Eli Lilly's experimental weight loss drug
Fact checked by Jennifer Klump Key Takeaways In the latest clinical trial, Eli Lilly's retatrutide helped participants lose up to 28.7% of their body weight. Some participants dropped out of the trial ...
CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of ...
For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel ...
Adults with obesity receiving tirzepatide 15 mg achieved greater weight loss than those receiving a fixed-dose combination of ...
The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...
Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results